NDAINJECTIONINJECTABLE
Approved
Nov 1948
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
XYLOCAINE is a combination local anesthetic and vasoconstrictor injection containing lidocaine hydrochloride and epinephrine bitartrate. It is used for local anesthesia in minor surgical and dental procedures by blocking nerve conduction. The epinephrine component prolongs anesthetic effect and reduces systemic absorption by causing vasoconstriction.
LOE Approaching
As a mature product approaching loss of exclusivity with moderate competitive pressure (30), commercial teams are likely focused on defensive positioning and cost management rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)
Started Feb 2011
27 enrolled
Morton's Neuroma
Career Relevance
Working on XYLOCAINE in a LOE-approaching phase offers limited career growth in commercial or clinical roles, with focus shifting to operational efficiency and cost defense. Professionals seeking innovation-driven positions should consider this a legacy portfolio assignment best suited for those building supply chain, manufacturing, or regulatory expertise.
Supply Chain Manager
Worked on XYLOCAINE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.